Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
1h
on MSN
GSK RSV shot 43% effective against severe disease in third year
GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...
1h
Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...
2h
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Mexican mayor assassinated
Sex abuse case dismissed
Milton becomes Category 5
Human life expectancy study
Harris on '60 Minutes'
Ranger dies during rescue
Richest female musician
Tickets to climb to $5
Vanderbilt, Arkansas fined
Musk's X appeal rejected
Intel defensive briefings rise
Ordered to open app store
Grammy-winning singer dies
NC voting rule changes
King named grand marshal
Liquidation plan approved
Hamas backers sanctioned
Win Nobel Prize in physics
Launches asteroid probe
Settles latest civil lawsuit
North Dakota wildfires
TX emergency abortion case
US antitrust case advances
Athlete payments approval
Hera mission launched
Targeted by a cyberattack
US overdose deaths drop
Names new school board
IVF clinic's appeal rejected
Feedback